New drug policy, regulations slowing down pharma growth: report

New Delhi: Hit by the new drug pricing policy and regulatory interventions, growth rate of the Rs. 72,069-crore Indian pharmaceutical market has slowed down to9.8 per cent in 2013 as compared to 16.6 per cent in 2012, says a report.

The pharma industry is also witnessing challenges like delays in clinical trial approvals, uncertainties over the FDI policy, a uniform code for sales and marketing practices and compulsory licensing, according to the report by CII-PwC.

Read the source article at

About the Author

Leave a Reply